IM Cannabis (IMCC) Non Operating Income (2020 - 2025)
IM Cannabis' (IMCC) quarterly Non Operating Income came in at -$443159.3 in Q4 2025, down 29.51% year-on-year from -$628703.1 in Q4 2024, and down 242.16% quarter-over-quarter from $311726.4 in Q3 2025.
IM Cannabis (IMCC) Non Operating Income (2020 - 2025) Analysis & Trends
IM Cannabis' Non Operating Income history runs 6 years deep, the most recent figure standing at -$443159.3 for Q4 2025.
- On a quarterly basis, Non Operating Income fell 29.51% year-over-year to -$443159.3 in Q4 2025; TTM through Dec 2025 was -$379786.2, a 221.35% decrease from a year earlier, with the FY2025 full-year figure at -$50913.1, up 97.28% from the prior year.
- Non Operating Income retreated to -$443159.3 in Q4 2025 per IMCC's latest filing, from $311726.4 in the prior quarter.
- Across five years, Non Operating Income topped out at $19.2 million in Q4 2021 and bottomed at -$1.0 million in Q2 2024.
- The 5-year median for Non Operating Income is $184990.8 (2023), against an average of $2.2 million.
- Across the five-year window, Non Operating Income jumped 2691.27% in 2021 and plunged 161.42% in 2024, its largest moves.
- Year by year, Non Operating Income stood at $19.2 million in 2021, then tumbled by 66.13% to $6.5 million in 2022, then slumped by 72.21% to $1.8 million in 2023, then tumbled by 118.89% to -$342175.9 in 2024, then retreated by 29.51% to -$443159.3 in 2025.
- Per Business Quant, the three latest IMCC Non Operating Income figures stand at -$443159.3 (Q4 2025), $311726.4 (Q3 2025), and $93822.6 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -7.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | IM Cannabis | 554,496.00 | -177,626.51 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -443,159.32 |
| Sep 30, 2025 | 311,726.42 |
| Jun 30, 2025 | 93,822.62 |
| Dec 31, 2024 | -342,175.89 |
| Sep 30, 2024 | -113,623.28 |
| Jun 30, 2024 | -1.04 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 184,990.76 |
| Jun 30, 2023 | 2.04 Mn |
| Dec 31, 2022 | 6.52 Mn |
| Sep 30, 2022 | -539,022.61 |
| Jun 30, 2022 | 807,870.87 |
| Mar 31, 2022 | -787,106.98 |
| Dec 31, 2021 | 19.24 Mn |
| Sep 30, 2021 | -314,586.09 |
| Jun 30, 2021 | 4.61 Mn |
| Mar 31, 2021 | 5.47 Mn |
| Dec 31, 2020 | -10.93 Mn |
| Sep 30, 2020 | 890,002.47 |
| Jun 30, 2020 | -4.96 Mn |